Gene · 6495
Papers2,008
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,008
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomic analysis uncovers the origin and intratumoral heterogeneity of parotid pleomorphic adenoma. | Int J Oral Sci | 2023 | 37679344 | PubTator, text mining | PubMed |
| Time-resolved quantitative proteomic analysis of the developing Xenopus otic vesicle reveals putative congenital hearing loss candidates. | iScience | 2023 | 37670778 | PubTator, text mining | PubMed |
| CHD7 variants associated with hearing loss and enlargement of the vestibular aqueduct. | Hum Genet | 2023 | 37668839 | PubTator, text mining | PubMed |
| Construction of lncRNA-miRNA-mRNA regulatory network in severe asthmatic bronchial epithelial cells: A bioinformatics study. | Medicine (Baltimore) | 2023 | 37657025 | PubTator, text mining | PubMed |
| The Role and Applications of Exosomes in Gynecological Cancer: A Review. | Cell Transplant | 2023 | 37632354 | PubTator, text mining | PubMed |
| Umbilical cord mesenchymal stem cells for regenerative treatment of intervertebral disc degeneration. | Front Cell Dev Biol | 2023 | 37601097 | PubTator, text mining | PubMed |
| The sulfotransferase XB5850668.L is required to apportion embryonic ectodermal domains. | Dev Dyn | 2023 | 37597164 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
| A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity. | Reprod Sci | 2023 | 37580647 | PubTator, text mining | PubMed |
| Research Progress of Maternal Metabolism on Cardiac Development and Function in Offspring. | Nutrients | 2023 | 37571325 | PubTator, text mining | PubMed |
| Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities. | Cancers (Basel) | 2023 | 37568749 | PubTator, text mining | PubMed |
| CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma. | J Exp Clin Cancer Res | 2023 | 37563692 | PubTator, text mining | PubMed |
| Biomarkers for patients with Wilms tumor: a review. | Front Oncol | 2023 | 37554168 | PubTator, text mining | PubMed |
| [Effect of Inhibiting SIX1 Expression on Drug-resistance of Acute Myeloid Leukemia Cell Line HL-60/ADR Cells]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 37551474 | PubTator, text mining | PubMed |
| RDRGSE: A Framework for Noncoding RNA-Drug Resistance Discovery by Incorporating Graph Skeleton Extraction and Attentional Feature Fusion. | ACS Omega | 2023 | 37546619 | PubTator, text mining | PubMed |
| scRNA-sequencing in chick suggests a probabilistic model for cell fate allocation at the neural plate border. | Elife | 2023 | 37530410 | PubTator, text mining | PubMed |
| Macrophage's role in solid tumors: two edges of a sword. | Cancer Cell Int | 2023 | 37525217 | PubTator, text mining | PubMed |
| Patterns of transcription factor binding and epigenome at promoters allow interpretable predictability of multiple functions of non-coding and coding genes. | Comput Struct Biotechnol J | 2023 | 37520281 | PubTator, text mining | PubMed |
| Derivation and characteristics of induced pluripotent stem cells from a patient with acute myelitis. | Front Cell Dev Biol | 2023 | 37519296 | PubTator, text mining | PubMed |
| HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2023 | 37515378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6495/papers?page=10